Seite - 51 - in Advances in Neuroimmunology

BrainSci. 2016,6, 18 77. Sinha, S.; Kaler, L.J.; Proctor, T.M.; Teuscher, C.; Vandenbark, A.A.; Offner, H. IL-13-mediated gender difference in susceptibility to autoimmuneencephalomyelitis. J. Immunol. (Baltim. Md. 1950) 2008, 180, 2679–2685. [CrossRef] 78. Verdu, E.F.; Deng, Y.; Bercik, P.; Collins, S.M.Modulatory effects of estrogen in twomurinemodels of experimental colitis.Am. J.Physiol. Gastrointest. LiverPhysiol. 2002,283, 27–36. [CrossRef] [PubMed] 79. Kawahara,K.;Suenobu,M.;Yoshida,A.;Koga,K.;Hyodo,A.;Ohtsuka,H.;Kuniyasu,A.;Tamamaki,N.; Sugimoto,Y.;Nakayama,H. Intracerebralmicroinjectionof interleukin-4/interleukin-13reducesβ-amyloid accumulation in the ipsilateral sideandimprovescognitivedeficits inyoungamyloidprecursorprotein23 mice.Neuroscience2012,207, 243–260. [CrossRef] [PubMed] 80. Man(OMIM)database.Availableonline: http://www.omim.org(accessedon9June2016). 81. Frank-Cannon, T.C.; Tran, T.; Ruhn,K.A.;Martinez, T.N.;Hong, J.;Marvin,M.;Hartley,M.; Trevino, I.; O’Brien, D.E.; Casey, B.; et al. Parkin deficiency increases vulnerability to inflammation-related nigral degeneration. J.Neurosci. 2008,28, 10825–10834. [CrossRef] [PubMed] ©2016bytheauthors. LicenseeMDPI,Basel,Switzerland. Thisarticle isanopenaccess articledistributedunder the termsandconditionsof theCreativeCommonsAttribution (CCBY) license (http://creativecommons.org/licenses/by/4.0/). 51